SomaLogic Inc - Product Pipeline Analysis, 2018 Update

SomaLogic Inc - Product Pipeline Analysis, 2018 Update

  • Products Id :- GDME50805PD
  • |
  • Pages: 48
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company's products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the properties of antibodies and aptamers, which is used in clinical diagnosis of EDTA plasma, citrate plasma, serum, CSF, tissue homogenate, cell lysates and conditioned cell media. SomaLogic's SOMAscan assay is a protein biomarker discovery and development tool for protein measurement solutions. It offers protein-measurement assays, kits, and reagents for life science and biopharma researchers. The company serves biological and medical science sectors. SomaLogic is headquartered in Boulder, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company SomaLogic Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

SomaLogic Inc Company Overview 6

SomaLogic Inc Company Snapshot 6

SomaLogic Inc Pipeline Products and Ongoing Clinical Trials Overview 6

SomaLogic Inc-Pipeline Analysis Overview 9

SomaLogic Inc-Key Facts 9

SomaLogic Inc-Major Products and Services 10

SomaLogic Inc Pipeline Products by Development Stage 11

SomaLogic Inc Pipeline Products Overview 13

SOMAscan Assay-Acute Lung Injury 13

SOMAscan Assay-Acute Lung Injury Product Overview 13

SOMAscan Assay-Alzheimer's Disease 14

SOMAscan Assay-Alzheimer's Disease Product Overview 14

SOMAscan Assay-Amyotrophic Lateral Sclerosis 15

SOMAscan Assay-Amyotrophic Lateral Sclerosis Product Overview 15

SOMAscan Assay-Cardiovascular Event Prediction 16

SOMAscan Assay-Cardiovascular Event Prediction Product Overview 16

SOMAscan Assay-Childhood Diseases 17

SOMAscan Assay-Childhood Diseases Product Overview 17

SOMAscan Assay-Chronic Renal Failure 18

SOMAscan Assay-Chronic Renal Failure Product Overview 18

SOMAscan Assay-Coronary Artery Disease 19

SOMAscan Assay-Coronary Artery Disease Product Overview 19

SOMAscan Assay-Depression 20

SOMAscan Assay-Depression Product Overview 20

SOMAScan Assay-Diabetic Retinopathy 21

SOMAScan Assay-Diabetic Retinopathy Product Overview 21

SOMAscan Assay-Duchenne Muscular Dystrophy 22

SOMAscan Assay-Duchenne Muscular Dystrophy Product Overview 22

SOMAscan Assay-Liver Fibrosis 23

SOMAscan Assay-Liver Fibrosis Product Overview 23

SOMAScan Assay-Lung Cancer 24

SOMAScan Assay-Lung Cancer Product Overview 24

SOMAscan Assay-Melanoma 25

SOMAscan Assay-Melanoma Product Overview 25

SOMAscan Assay-Mesothelioma Cancer 26

SOMAscan Assay-Mesothelioma Cancer Product Overview 26

SOMAscan Assay-Multiple Sclerosis 27

SOMAscan Assay-Multiple Sclerosis Product Overview 27

SOMAscan Assay-Obesity 28

SOMAscan Assay-Obesity Product Overview 28

SOMAscan Assay-Ovarian Cancer 29

SOMAscan Assay-Ovarian Cancer Product Overview 29

SOMAscan Assay-Pancreatic Cancer 30

SOMAscan Assay-Pancreatic Cancer Product Overview 30

SOMAscan Assay-Parkinson's Disease 31

SOMAscan Assay-Parkinson's Disease Product Overview 31

SOMAscan Assay-Preterm Labor 32

SOMAscan Assay-Preterm Labor Product Overview 32

SOMAscan Assay-Renal Cell Carcinoma 33

SOMAscan Assay-Renal Cell Carcinoma Product Overview 33

SOMAscan Assay-Rheumatoid Arthritis 34

SOMAscan Assay-Rheumatoid Arthritis Product Overview 34

SOMAscan Assay-Sepsis 35

SOMAscan Assay-Sepsis Product Overview 35

SOMAscan Assay-Tuberculosis 36

SOMAscan Assay-Tuberculosis Product Overview 36

SomaLogic Inc-Key Competitors 37

SomaLogic Inc-Key Employees 38

SomaLogic Inc-Locations And Subsidiaries 39

Head Office 39

Recent Developments 40

SomaLogic Inc, Recent Developments 40

Jun 06, 2018: SomaLogic: Translating the Book of Life 40

Apr 02, 2018: Melody Harris, J.D., Appointed Chief Legal Officer of SomaLogic 40

Mar 30, 2018: SomaLogic Launches New Version of SOMAscan Assay 41

Feb 06, 2018: SomaLogic Teams with Leeds Centre for Personalised Medicine and Health to Deliver SOMAscan Platform in Clinical Healthcare 41

Dec 26, 2017: SomaLogic: Large-scale profiling of blood proteins identifies new markers of heart damage 41

Apr 05, 2017: SomaLogic announces the appointment of long-time Board member as Chief Executive Officer 42

Feb 08, 2016: The University of Oxford and SomaLogic Announce Wide Ranging Agreement for Protein Biomarker Discovery and Clinical Applications Development 42

Dec 17, 2015: VU University Medical Center Amsterdam Is First Continental European SOMAscan Assay Site 43

Dec 14, 2015: FDA's National Center for Toxicological Research is latest site of SOMAscan assay 43

Dec 07, 2015: SomaLogic and Otsuka Pharmaceutical Scientists Publish Study Demonstrating Therapeutic Potential of a Novel SOMAmer Reagent for Rheumatoid Arthritis 44

Appendix 45

Methodology 45

About GlobalData 48

Contact Us 48

Disclaimer 48

List of Figures

SomaLogic Inc Pipeline Products by Equipment Type 7

SomaLogic Inc Pipeline Products by Development Stage 11

List of Tables

SomaLogic Inc Pipeline Products and Ongoing Clinical Trials Overview 6

SomaLogic Inc Pipeline Products by Equipment Type 7

SomaLogic Inc Pipeline Products by Indication 8

SomaLogic Inc, Key Facts 9

SomaLogic Inc, Major Products and Services 10

SomaLogic Inc Number of Pipeline Products by Development Stage 11

SomaLogic Inc Pipeline Products Summary by Development Stage 12

SOMAscan Assay-Acute Lung Injury-Product Status 13

SOMAscan Assay-Acute Lung Injury-Product Description 13

SOMAscan Assay-Alzheimer's Disease-Product Status 14

SOMAscan Assay-Alzheimer's Disease-Product Description 14

SOMAscan Assay-Amyotrophic Lateral Sclerosis-Product Status 15

SOMAscan Assay-Amyotrophic Lateral Sclerosis-Product Description 15

SOMAscan Assay-Cardiovascular Event Prediction-Product Status 16

SOMAscan Assay-Cardiovascular Event Prediction-Product Description 16

SOMAscan Assay-Childhood Diseases-Product Status 17

SOMAscan Assay-Childhood Diseases-Product Description 17

SOMAscan Assay-Chronic Renal Failure-Product Status 18

SOMAscan Assay-Chronic Renal Failure-Product Description 18

SOMAscan Assay-Coronary Artery Disease-Product Status 19

SOMAscan Assay-Coronary Artery Disease-Product Description 19

SOMAscan Assay-Depression-Product Status 20

SOMAscan Assay-Depression-Product Description 20

SOMAScan Assay-Diabetic Retinopathy-Product Status 21

SOMAScan Assay-Diabetic Retinopathy-Product Description 21

SOMAscan Assay-Duchenne Muscular Dystrophy-Product Status 22

SOMAscan Assay-Duchenne Muscular Dystrophy-Product Description 22

SOMAscan Assay-Liver Fibrosis-Product Status 23

SOMAscan Assay-Liver Fibrosis-Product Description 23

SOMAScan Assay-Lung Cancer-Product Status 24

SOMAScan Assay-Lung Cancer-Product Description 24

SOMAscan Assay-Melanoma-Product Status 25

SOMAscan Assay-Melanoma-Product Description 25

SOMAscan Assay-Mesothelioma Cancer-Product Status 26

SOMAscan Assay-Mesothelioma Cancer-Product Description 26

SOMAscan Assay-Multiple Sclerosis-Product Status 27

SOMAscan Assay-Multiple Sclerosis-Product Description 27

SOMAscan Assay-Obesity-Product Status 28

SOMAscan Assay-Obesity-Product Description 28

SOMAscan Assay-Ovarian Cancer-Product Status 29

SOMAscan Assay-Ovarian Cancer-Product Description 29

SOMAscan Assay-Pancreatic Cancer-Product Status 30

SOMAscan Assay-Pancreatic Cancer-Product Description 30

SOMAscan Assay-Parkinson's Disease-Product Status 31

SOMAscan Assay-Parkinson's Disease-Product Description 31

SOMAscan Assay-Preterm Labor-Product Status 32

SOMAscan Assay-Preterm Labor-Product Description 32

SOMAscan Assay-Renal Cell Carcinoma-Product Status 33

SOMAscan Assay-Renal Cell Carcinoma-Product Description 33

SOMAscan Assay-Rheumatoid Arthritis-Product Status 34

SOMAscan Assay-Rheumatoid Arthritis-Product Description 34

SOMAscan Assay-Sepsis-Product Status 35

SOMAscan Assay-Sepsis-Product Description 35

SOMAscan Assay-Tuberculosis-Product Status 36

SOMAscan Assay-Tuberculosis-Product Description 36

SomaLogic Inc, Key Employees 38

Glossary 47

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Targeted Diagnostics & Therapeutics Inc

Quotient Biodiagnostics Inc

Life Technologies Corp

ARK Diagnostics Inc

Alfa Wassermann Diagnostic Technologies, LLC

Affymetrix, Inc.

SomaLogic Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53520
Site License
USD 1500 INR 107040
Corporate User License
USD 2250 INR 160560



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]